An advertisement for the product Quit Nits products, which we published on the website, contained statements that require correction.

A complaint about the advertisement was upheld by the Complaints Resolution Panel, which found that the advertisement contained misleading claims in breach of the Therapeutic Goods Advertising Code.

We claimed that Quit Nits One is “clinically proven” to kill head lice and to be “99 percent effective”. These are high level claims which require stronger evidence than that which we provided. We were also unable to provide evidence to the Panel to substantiate other claims that we made.

The full text of the Panel’s determination can be found at: 

View the Wild Child company website here: